The involvement of CYP2U1 in the metabolism of LTB4 could have strong physiological consequences in cerebral pathological events including ischemic stroke because CYP2U1 is predominantly expressed in the brain whereas CYP4F2/4F3 are mainly expressed in liver and neutrophiles. Here, CYP4F2 is linked to ischemic stroke.